FORM 4
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL
---------------
OMB Number 3235-0287
Expires: December 31, 2001
Estimated average
burden hours per
response ........................0.5
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
|_| Check this box if no longer
subject to Section 16. Form 4
or Form 5 obligations may
continue. See Instruction 1(b).
Filed pursuant to Section 16(a) of the Securities
Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section
30(f) of the Investment Company Act of 1940
(Print or Type Responses)
- ---------------------------------- ---------------------------------------------
1. Name and Address of 2. Issuer Name and Ticker
Reporting Person or Trading Symbol
ALFORD DONALD C. U.S. LABORATORIES INC. (USLB)
- ---------------------------------- ---------------------------------------------
(Last) (First) (Middle) 3. IRS or Social Security
Number of Reporting
646 San Antonio Avenue Person (Voluntary)
- ----------------------------------
(Street)
San Diego, California 92106
- ----------------------------------
(City) (State) (Zip)
- ---------------------------------- ---------------------------------------------
4. Statement for 5. If Amendment, Date of Original
Month/Year (Month/Year)
May 1999
6. Relationship of Reporting Person to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give _____ Other (specify
title below) below)
7. Individual or Joint/Group Filing (Check Applicable
Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
<PAGE>
<TABLE>
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
<CAPTION>
1. Title of 2. Trans- 3. Trans- 4. Securities 5. Amount of 6. Ownership 7. Nature of
Security action action Acquired (A) Securities Form: Indirect
(Instr. 3) Date Code or Disposed of (D) Beneficially Direct (D) Beneficial
(Month/ (Instr. 8) (Instr. 3, 4 and 5) Owned at End or Indirect Ownership
Day/ of Month (Instr. (I) (Instr. 4) (Instr. 4)
3 and 4)
--------------------------------------------
(A) or
Code V Amount (D) Price
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
COMMON STOCK 5/15/99 P 5,000 A $4.00 58,478 D
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
SEC 1474 (7/96)
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
<PAGE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of 2. Conver- 3. Trans- 4. Trans- 5. Number of 6. Date Exer- 7. Title and Amount
Derivative sion or action action Derivative cisable and of Underlying
Security Exercise Date Code Securities Expiration Date Securities
(Instr. 3) Price of Month/ (Instr. Acquired (Month/Day/ (Instr. 3 and 4)
Deriv- Day/ 8) (A) or Year)
ative Year) Disposed
Security of (D)
(Instr.
3, 4 and
5)
----------------------------------------------------
Date Expiration Title Amount or
Exer- Date Number of
cisable Shares
------------------------------
Code V (A) (D)
- ---------------------------------------------------------- ------ ----- ------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
8. Price 9. Number 10. Owner- 11. Nature of
of of Deriv- ship Form In-direct
Deriv- ative Secu- of Derivative Beneficial
ative rities Bene- Security; Ownership
Secu- ficially Direct (Instr. 4)
rity Owned at (D) or
(Instr. End of Indirect (I)
5) Month (Instr. 4)
(Instr. 4)
<S> <C> <C> <C>
- -------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
/s/Donald Alford June 8, 1999
See 18 U.S.C. 1001 and ** Signature of Reporting Person Date
15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, see Instruction 6 for procedure.
